Tuesday, 02 January 2024 12:17 GMT

QRCS Supports Syria's Cancer Referrals To Türkiye


(MENAFN- The Peninsula) The Peninsula

Doha, Qatar: Pursuing its humanitarian efforts to support vulnerable patients in Syria and facilitate their access to specialised healthcare, Qatar Red Crescent Society (QRCS) has recently opened a residential centre for Syrian patients with cancer referred for treatment in Türkiye as part of a larger project implemented by the Independent Doctors Association (IDA).

The project is aimed at ensuring a safe and supportive environment for the patients and their families coming from Syria with no place for residence during their stay for treatment in Türkiye.

It would help alleviate their health and living burdens, improve their quality of life, and enhance their prospects of recovery.

Over a period of 11 months, the centre will host around 1,000 referred patients from Syria.

It will provide appropriate accommodation up to medically recommended health standards, specialised nutrition programmes, transportation to and from Turkish hospitals, psychosocial support, interpreting, and physiotherapy.

Moreover, the project covers some additional medical expenses not covered by the Turkish health system and provides one-time e-coupons to purchase food and nonfood items from contracted stores. The centre is run by a full team of case managers, interpreters, nutritionists, psychological support specialists, and administrative/technical staff to ensure the quality of services provided for inmates.

Other components of the project include the rehabilitation and equipment of some facilities at the Al-Amal Association Centre to increase its capacity and improve the care environment.
More than 5,000 persons from the patients' families and community are expected to indirectly benefit from the project. In the same vein, the QRCS is raising funds to provide chemotherapy and immunotherapy drugs for 400 displaced and poor Syrian patients with cancer at the Oncology Centre in Syria.

The cost of treatment is only QR10,000 per patient.

MENAFN26082025000063011010ID1109975429

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search